Clayface wins the weekend on a budget DC can actually live with
Clayface is estimated at a $24 million to $25 million opening on a $44 million net cost, with an A- CinemaScore and no IMAX. How that stacks up against Superman, Supergirl and October horror, and what to watch next.
Clayface won the weekend, and the number I keep staring at is not the opening. It is the budget. Warner Bros. and DC Studios opened the James Watkins film in 3,458 North American theaters on Friday, and Deadline's Saturday update has it pointing to a $24 million to $25 million three-day start after a $10.4 million Friday that includes Thursday previews. That is a No. 1 finish for a Batman villain movie with no Batman in it. Deadline puts the net production cost at $44 million before marketing.
These are weekend estimates, not final numbers. Actuals land on Monday, and an estimate built off a Friday can move a million either way. I am fine with that, because the shape of this weekend is already clear, and the shape is the story.
What Clayface is, in one breath
Premise only, no spoilers. Tom Rhys Harries plays Matt Hagen, a rising actor whose face is badly disfigured, who signs up for an experimental procedure to get it back. Variety lists Naomi Ackie, David Dencik, Max Minghella and Eddie Marsan in the cast. Mike Flanagan wrote the story and co-wrote the script with Hossein Amini, and iHorror notes it is the first R rating in James Gunn's DC Universe. If you want the director's own pitch for the tone, our September look at the dinner party pitch holds up: this was sold as a horror film first and a DC film second.
DC's recent run, side by side
Here is what this weekend's box office coverage reported about the DC films it compared Clayface against. Blank cells mean the figure was not in these reports, and I am not going to guess at it.
| Film | Reported production cost | Opening-night CinemaScore | Box office cited this weekend |
|---|---|---|---|
| Superman (2025) | Nearly $230 million (Variety) | A- (Deadline) | $618.72 million worldwide (Variety) |
| The Flash (2023) | Not reported here | B (Deadline) | Not reported here |
| Supergirl (2026) | $170 million (Variety) | B- (Deadline) | $126 million, called a bomb (Variety) |
| Clayface (2026) | $44 million net (Deadline, Variety) | A- (Deadline) | $24 million to $25 million opening, estimated (Deadline) |
Read that table from the cost column outward. Supergirl cost almost four times what Clayface did and finished with a worldwide total that would not have covered its own production line. Superman made real money, but it needed a $230 million build to do it. Clayface, if the estimate holds, has earned back more than half its production cost in North America in one weekend. Theatrical rentals and marketing make that math messier than it looks, and I am not pretending otherwise. As a ratio, though, it is the healthiest number DC has posted in a while.
A $44 million monster movie that opens to roughly $24 million is not a miracle. It is something better. It is repeatable.
The A- is the stranger number
CinemaScore polls opening-night audiences, and horror almost never grades well there. The genre is built to send people out rattled. iHorror points out that this month's Other Mommy won its weekend with $27.5 million and a D+, and it quotes Gunn on Threads saying that Sinners is the only horror movie to have ever earned an A. Clayface got an A-, the same grade Deadline reports for Superman, and better than Supergirl's B- and The Flash's B.
That matters for the next two weekends more than this one. A bad grade on a front-loaded genre film usually means a steep second-week drop. A good one gives a movie room to hold, and Clayface has Halloween sitting right in front of it. Deadline thinks the holiday frame will be rough for the whole market because Halloween falls on a Saturday, so a film people actually recommend is in a better spot than most.
It did this without IMAX
This is my favorite detail in Deadline's report. Clayface had no IMAX screens, because Street Fighter had the format booked for two weeks (the same IMAX split I flagged back when Clayface was leading the interest tracking), yet premium large formats still delivered close to half the weekend's gross. That means the other big rooms: Dolby, XD, RPX and the chains' house formats. If you want to know where those rooms are near you, our guide to IMAX and premium screens lists them by format. A body horror film pulling half its money from upgraded seats tells me people treated this as an event, not a Tuesday streaming catch.
Speaking of Street Fighter: Deadline has it falling about 74% in its second weekend, which makes Clayface the second straight No. 1 opener for the merged Paramount and Warner Bros. after Street Fighter's $31 million debut. I covered how critics read Street Fighter last week. The two films could not be built more differently, one a big brawler with a front-loaded crowd, the other a mid-budget horror film that audiences graded like a crowd-pleaser.
How it sits against other October horror
Deadline's own comparison for the opening was other mid-October genre films:
- Smile opened to $22.6 million.
- Black Phone 2 opened to $27.2 million last year.
- Other Mommy opened to $27.5 million this month, per iHorror.
- Clayface is estimated at $24 million to $25 million.
So Clayface did not break the genre ceiling. It landed right in the pocket where good studio horror usually lands. What makes it different is the logo on the poster. A DC villain film that performs like a solid horror release, and costs like one, is a new kind of product for Warner Bros., and I suspect that is the takeaway inside the studio this morning.
What I would watch next
Three things. First, Monday's actuals, to see whether the $24 million to $25 million estimate holds. Second, the drop into Halloween weekend, which will tell us whether that A- was real enthusiasm or just a happy opening-night crowd. Third, overseas. TheWrap expects this to be a domestic-leaning performer, which is normal for horror and fine at this price.
Deadline also passed along RelishMix chatter about fans pitching more villain films in the same vein. I would not read a sequel or a spinoff into a social media summary. What I would read into it is simpler. DC finally has a cheap, scary, R-rated proof of concept that made its money back on the right timeline, and the lesson for the next one is not "make it bigger." It is "keep it this size."
How we made this: researched and drafted with AI assistance. Sources are linked in the piece.
How we made this: researched and drafted with AI assistance. Sources are linked in the piece.
Original commentary based on public reporting. Not a reprint. Editorial standards.
